Cleveland Clinic 5th Annual Cleveland Breast Cancer Summit 2019

Regular price
$10.00
Sale price
$10.00
Regular price
$0
Sold out
Unit price
Quantity must be 1 or more

Cleveland Clinic 5th Annual Cleveland Breast Cancer Summit 2019

Format:19 videos, size: 5 GB

Course Audience: oncologist

Augmenting the Cancer Immunity Cycle (Video MP4 Format)

CAR-T Cell Therapy for Breast Cancer Types of T-Cell Therapy, Identifying Target Cancer-Antigen, Mesothelin Directed CAR T Therapy & Saving T-Cells from Exhaustion (Video MP4 Format)

Case Adjuvant Systemic and Radiation Therapy Options for 68 yo Patient with ER+, HER2+ Breast Cancer (Video MP4 Format)

Case of a 35 yo Woman with Micrometastatic Carcinoma, RCB-II Whose Disease Relapse Into ER+, PR-, HR2 (Video MP4 Format)

Case of a 65 yo Woman with DCIS Breast Cancer, pN1 Micrometastases and Weakly ER+ Surgical and Systemic Treatment Discussion (Video MP4 Format)

Current Concept of Breast Cancer Vaccines Study on HER2 Directed Vaccine in Combo with HER2 Directed Trastuzumab & Checkpoint Inhibitors + Vaccines (Video MP4 Format)

Current Standard of Care For Breast Cancer With Radiation Therapy Can the Length of Radiation Treatment be Reduced & Does the Whole Breast Need to Be Irradiated (Video MP4 Format)

Current State of Breast Cancer Vaccines Testing Vaccines in Adjuvant Setting, HER2 as a Target of Immune Response and Related Trials (Video MP4 Format)

Discussions on Approach to Ipsilateral Breast Tumor Recurrences with Case Example (Video MP4 Format)

Enhancing the Impact of Immunotherapy in TNBC IO Therapy Options in Early Stage Disease (Video MP4 Format)

Evolving Strategies for Enhancing the Impact of Immunotherapy in Breast Cancer (Video MP4 Format)

Imaging Response to Treatment Challenges of Immunotherapy Discussion of Patterns of Immune-Related Adverse Effects (Video MP4 Format)

Improving the response to immunotherapy Turning cold tumors hot (Video MP4 Format)

NCCN Guidelines Update for ER+ Breast Cancer CDK46 and PIK3CA Inhibitors for Advanced BC & Tamoxifen and Aromatase Inhibitors for Early BC (Video MP4 Format)

NCCN Guidelines Update for TNBC and HER2 Breast Cancer Immunotherapy and PARP Inhibitors in TNBC & Trastuzumab Biosimilars in HER2 BC (Video MP4 Format)

Overview of Current Response Imaging Patterns to Immunotherapy (Video MP4 Format)

Q&A on Clinical Data Behind Changing the Guidelines, Her2+ Testing in DCIS, Centromeric Probes, PDL-1 in TNBC, Changes in Fish Ratio & Heterogeneous HER2 (Video MP4 Format)

Review of HER2 Testing Guidelines in Breast Cancer With Cases – IHC Equivocal Definition, Repeating Testing if Initially Negative Test on Core Biopsy, & HER2 Genotypes (Video MP4 Format)

Therapeutic Options for Systemic Treatment of TNBC & New Data on PDL-1 and Immunotherapy (Video MP4 Format)

Go to full site